Important Safety Information

  • The most common adverse reactions in clinical studies (≥ 3% of Aimovig-treated patients and more often than placebo) were injection site reactions and constipation.

Please see Aimovig full Prescribing Information.


Indication

Aimovig is indicated for the preventive treatment of migraine in adults.
Hypothetical patient.

Migraine can have a disabling impact on your patients’ lives

Migraine is one of the

TOP 10
causes of years lived with disability worldwide1
 
'Migraine is one of the top 10 causes of years lived with disability worldwide

For many patients, migraine impacts family and social life2:

Episodic Migraine2*

Episodic Migraine

2out
of3

patients with
episodic migraine

Patients with episodic migraine missed their share of housework and family activities

1out
of4

patients with
episodic migraine

Patients with episodic migraine missed an important event such as a wedding or graduation

Chronic Migraine2

Chronic Migraine

3out
of4

patients with
chronic migraine

Patients with episodic migraine missed their share of housework and family activities

2out
of5

patients with
chronic migraine

Patients with episodic migraine missed an important event such as a wedding or graduation

*In a survey of episodic migraines with 5 to 14 headache days per month.
A partner or spouse had to take over the share of work for a person with migraine and/or the person with migraine did not participate in family activities at home.

Mechanism of Action

Indication

Aimovig is indicated for the preventive treatment of migraine in adults.

Important Safety Information

Please see Aimovig full Prescribing Information.

References: 1. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries. 1990-2016: a systemic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211-1259. 2. Buse DC, Scher AI, Dodick DW, et al. Impact of migraine on the family: perspectives of people with migraine and their spouse/domestic partner in the CaMEO study. Mayo Clin Proc. 2016;91(5):596-611.